Patents by Inventor Marshall L. Sherman

Marshall L. Sherman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130331831
    Abstract: Devices, systems and methods are disclosed for the ablation of tissue. Embodiments include an ablation catheter which has an array of ablation elements attached to a deployable carrier assembly. The carrier assembly can be constrained within the lumen of a catheter, and deployed to take on an expanded condition.
    Type: Application
    Filed: May 30, 2013
    Publication date: December 12, 2013
    Applicant: MEDTRONIC ABLATION FRONTIERS LLC
    Inventors: Randell L. WERNETH, Marshall L. SHERMAN, Thomas M. CASTELLANO, J. Christopher FLAHERTY, Gary Edward CURRIE
  • Publication number: 20130296679
    Abstract: Systems and methods for assessing electrode position, including positioning a plurality of electrodes within a heart and proximate a pulmonary vein; obtaining an impedance measurement from each of the plurality of electrodes; determining whether any of the plurality of electrodes is located within the pulmonary vein based at least in part on the obtained impedance measurements; and generating an indication if at least one of the plurality of electrodes is determined to be located within the pulmonary vein.
    Type: Application
    Filed: May 1, 2012
    Publication date: November 7, 2013
    Applicant: MEDTRONIC ABLATION FRONTIERS LLC
    Inventors: Catherine R. CONDIE, Marshall L. SHERMAN, Mark T. STEWART
  • Publication number: 20130296839
    Abstract: A method and system for detecting microbubble formation during a radiofrequency ablation procedure. The method includes measuring an impedance of a pair of electrodes, at least one electrode in the pair of electrodes being coupled to a treatment assembly of a medical device. Radiofrequency ablation energy is transmitted between the pair of electrodes. The transmission of radiofrequency ablation energy between the pair of electrodes is terminated when after a predetermined period of time the measured impedance in either of the electrodes in the pair of electrodes is a predetermined percentage above a measured minimum impedance and a measured power is above a predetermined power threshold. An alert is generated indicating at least one of the formation and release of microbubbles proximate the pair of electrodes.
    Type: Application
    Filed: May 1, 2012
    Publication date: November 7, 2013
    Applicant: MEDTRONIC ABLATION FRONTIERS LLC
    Inventors: Catherine R. CONDIE, Marshall L. SHERMAN, Mark T. STEWART
  • Publication number: 20130296840
    Abstract: Systems and methods for assessing tissue contact, including positioning an electrode adjacent a tissue region; delivering radiofrequency energy to the electrode, wherein the delivered radiofrequency energy is sufficient to ablate at least a portion of the tissue region; obtaining a plurality of impedance measurements from the electrode during the delivery of the radiofrequency energy; calculating a change in the impedance measurements over a pre-determined time period; and generating an alert if the calculated change is less than a pre-defined value.
    Type: Application
    Filed: May 1, 2012
    Publication date: November 7, 2013
    Applicant: MEDTRONIC ABLATION FRONTIERS LLC
    Inventors: Catherine R. CONDIE, Marshall L. SHERMAN, Mark T. STEWART
  • Publication number: 20130289551
    Abstract: A method and system for detecting a short circuit during a radiofrequency ablation procedure. The method includes measuring an impedance of a pair of electrodes coupled to a treatment assembly of a medical device. Radiofrequency ablation energy is transmitted between the pair of electrodes. The transmission of radiofrequency ablation energy between the pair of electrodes is terminated when after a predetermined period of time the measured impedance in either of the electrodes in the pair of electrodes is below a predetermined threshold impedance value. An alert is generated indicating a short circuit between the pair of electrodes.
    Type: Application
    Filed: April 26, 2012
    Publication date: October 31, 2013
    Applicant: MEDTRONIC ABLATION FRONTIERS LLC
    Inventors: Catherine R. CONDIE, Marshall L. SHERMAN
  • Patent number: 8486063
    Abstract: Devices, systems and methods are disclosed for the ablation of tissue. Embodiments include an ablation catheter which has an array of ablation elements attached to a deployable carrier assembly. The carrier assembly can be constrained within the lumen of a catheter, and deployed to take on an expanded condition.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: July 16, 2013
    Assignee: Medtronic Ablation Frontiers LLC
    Inventors: Randell L. Werneth, Marshall L. Sherman, Thomas M. Castellano, J. Christopher Flaherty, Gary Edward Currie
  • Patent number: 8273084
    Abstract: An atrial ablation catheter and methods for its use. The endocardial catheter includes an electrode array particularly adapted to locate and ablate foci of arrhythmia which are required for sustained atrial fibrillation is provided. The array is easily deployed and retracted from the catheter, and presents a distally oriented electrode array that can be pressed against the wall of the atrium.
    Type: Grant
    Filed: August 25, 2008
    Date of Patent: September 25, 2012
    Assignee: Medtronic Ablation Frontiers LLC
    Inventors: Christopher G. Kunis, Thomas M. Castellano, Marshall L. Sherman, Randell L. Werneth
  • Publication number: 20120197243
    Abstract: A method of assessing a tissue ablation treatment, including positioning a medical device adjacent a target tissue; measuring a first impedance magnitude a first frequency with the medical device; measuring a first impedance phase at a second frequency with the medical device; ablating at least a portion of the target tissue with the medical device; measuring at second impedance magnitude at a third frequency with the medical device; measuring a second impedance phase at a fourth frequency with the medical device; comparing at least one of (i) the first and second impedance magnitudes and (ii) the first and second impedance phases; and providing an indication of the efficacy of the ablation treatment based at least in part on the comparison.
    Type: Application
    Filed: January 31, 2011
    Publication date: August 2, 2012
    Inventors: Marshall L. SHERMAN, Catherine R. CONDIE, Mark T. STEWART
  • Publication number: 20120136346
    Abstract: A medical method, device, and system are provided, including advancing an ablation element of a medical device into contact with tissue to be treated, selecting a power level of energy to ablate the tissue, delivering energy at the selected power level to the ablation element, determining whether the ablation element is in continuous contact with the tissue, and reducing the selected power level when the ablation element ceases to be in continuous contact with the tissue.
    Type: Application
    Filed: April 28, 2011
    Publication date: May 31, 2012
    Inventors: Catherine R. Condie, Marshall L. Sherman, Kathryn E. Kasischke, Timothy J. Corvi, Aaron R. Strunk
  • Publication number: 20120136348
    Abstract: A medical method, device, and system are provided, including advancing an ablation element of a medical device into contact with tissue to be treated, selecting a power level of energy to ablate the tissue, delivering energy at the selected power level to the ablation element, determining whether the ablation element is in continuous contact with the tissue, and reducing the selected power level when the ablation element ceases to be in continuous contact with the tissue.
    Type: Application
    Filed: April 28, 2011
    Publication date: May 31, 2012
    Inventors: Catherine R. Condie, Marshall L. Sherman, Kathryn E. Kasischke, Timothy J. Corvi, Aaron R. Strunk
  • Publication number: 20120109115
    Abstract: A method of assessing lesion quality of an ablated tissue region comprising ablating at least a portion of the tissue region. The reactance of the ablated tissue region is measured. The lesion quality of the ablated tissue region is determined based on the measured reactance.
    Type: Application
    Filed: October 28, 2010
    Publication date: May 3, 2012
    Applicant: MEDTRONIC ABLATION FRONTIERS LLC
    Inventors: Catherine R. CONDIE, Kathryn Elaine KASISCHKE, Marshall L. SHERMAN
  • Publication number: 20110190755
    Abstract: A medical device is provided, including an ablation system with a generator, at least one ablation element, a patient return electrode, and a feedback system to verify and monitor the electrical connection between the generator and the patient return electrode, as well as contact of the patient return electrode with the patient. If an electrical connection is absent, intermittent, or of low quality, the medical device may also provide notice, a warning or alarm, and may also automatically cease ablation occurring at that time.
    Type: Application
    Filed: January 29, 2010
    Publication date: August 4, 2011
    Applicant: MEDTRONIC ABLATION FRONTIERS LLC
    Inventors: Charu P. MATHUR, Marshall L. SHERMAN
  • Publication number: 20090182325
    Abstract: Devices, systems and methods are disclosed for the ablation of tissue. Embodiments include an ablation catheter that has an array of ablation elements attached to a deployable carrier assembly. The carrier assembly can be constrained within the lumen of a catheter, and deployed to take on an expanded condition. The carrier assembly includes multiple electrodes that are configured to ablate tissue at low power. Additional embodiments include a system that includes an interface unit for delivering one or more forms of energy to the ablation catheter.
    Type: Application
    Filed: December 19, 2008
    Publication date: July 16, 2009
    Inventors: Randell L. Werneth, Christopher G. Kunis, J. Christopher Flaherty, Marshall L. Sherman
  • Publication number: 20090030411
    Abstract: Devices, systems and methods are disclosed for the ablation of tissue. Embodiments include an ablation catheter which has an array of ablation elements attached to a deployable carrier assembly. The carrier assembly can be constrained within the lumen of a catheter, and deployed to take on an expanded condition.
    Type: Application
    Filed: October 3, 2008
    Publication date: January 29, 2009
    Inventors: Randell L. Werneth, Marshall L. Sherman, Thomas M. Castellano, J. Christopher Flaherty, Gary Edward Currie
  • Publication number: 20080306477
    Abstract: An atrial ablation catheter and methods for its use. The endocardial catheter includes an electrode array particularly adapted to locate and ablate foci of arrhythmia which are required for sustained atrial fibrillation is provided. The array is easily deployed and retracted from the catheter, and presents a distally oriented electrode array that can be pressed against the wall of the atrium.
    Type: Application
    Filed: August 25, 2008
    Publication date: December 11, 2008
    Inventors: Christopher G. Kunis, Thomas M. Castellano, Marshall L. Sherman, Randell L. Werneth
  • Publication number: 20080281322
    Abstract: A radio frequency tissue ablation system with a radio frequency generator, the generator comprising a radio frequency source, at least four independently controllable radio frequency outputs, a user interface and a controller configured to delivery radio frequency energy from the radio frequency source to the radio frequency outputs in one of at least two different output configurations in response to a configuration selection made through the user.
    Type: Application
    Filed: May 8, 2008
    Publication date: November 13, 2008
    Applicant: Ablation Frontiers, Inc.
    Inventors: Marshall L. Sherman, Randell L. Werneth, J. Christopher Flaherty
  • Patent number: 7429261
    Abstract: An atrial ablation catheter and methods for its use. The endocardial catheter includes an electrode array particularly adapted to locate and ablate foci of arrhythmia which are required for sustained atrial fibrillation is provided. The array is easily deployed and retracted from the catheter, and presents a distally oriented electrode array that can be pressed against the wall of the atrium.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: September 30, 2008
    Assignee: Ablation Frontiers, Inc.
    Inventors: Christopher G. Kunis, Thomas M. Castellano, Marshall L. Sherman, Randell L. Werneth
  • Patent number: 6761716
    Abstract: The efficacy of a lesion produced between a pair of ablation electrodes is assessed by analyzing the time it takes for a pulse of energy to travel from one electrode to the other. During a first time period, a first pulse of energy is applied to a first electrode. The time it takes for the pulse to conduct through the tissue to a second electrode is determined. During a time period subsequent to the first time, a subsequent pulse of energy is applied to the first electrode and the time it takes for the subsequent pulse to conduct through the tissue to the second electrode is determined. Changes in the conduction times are monitored by calculating the difference between consecutive conduction times and comparing the difference to a preset value. If the difference is below the preset value the lesion is considered adequate.
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: July 13, 2004
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Veerichetty A. Kadhiresan, Marshall L. Sherman, Wade A. Bowe
  • Patent number: 6752804
    Abstract: A catheter carries a plurality of electrodes, each with multiple thermal sensors attached and is used to position the electrodes proximal biological tissue. A processor responsive to each of the thermal sensors determines the temperature at the thermal-sensor/electrode junction. A display provides a graphic representation of the temperatures of the thermal-sensor/electrode junctions. An exemplary representation is a bar graph having the temperature of one thermal sensor at one end and the temperature of another thermal sensor at the other end. The length of the bar graph combined with the position of the bar graph relative to a temperature range region provides an indication of the position of the thermal-sensor/electrode junctions relative to the biological tissue. The processor also monitors the spread between the sensor temperatures and compares it to a threshold value. Base on the result of the comparison, the processor controls the power applied to the electrode.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: June 22, 2004
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: John A. Simpson, Marshall L. Sherman, David S. Wood, Jeffrey A. Hall
  • Publication number: 20030204185
    Abstract: Upon initial use of a catheter, a power control system writes data indicative of the date/time of the initial use to a memory device carried by the catheter. During continued use of the catheter the power control system periodically determines the difference between the stored date/time and the current date/time. For electrophysiological catheters, the power control system allows for an electrical interface with the catheter electrodes only when the difference is less than a set time period. The electrical interface may include the provision of ablation energy from the power control system to the electrodes or the receipt of signals from the electrodes indicative of electrical activity sensed by the electrodes. Alternatively, the power control system may provide a visual or audible overtime indication when the difference is greater than the set time period.
    Type: Application
    Filed: April 26, 2002
    Publication date: October 30, 2003
    Inventors: Marshall L. Sherman, Steven R. Katz, James C. Vorisek